Ilyang Flu Vaccine

**Ilyang Flu Vaccine** is a trivalent, inactivated split influenza vaccine developed and manufactured by IL-YANG Pharmaceutical Co., Ltd., a South Korean company. Produced using an egg-based process with fumigated chicken eggs and sucrose gradient purification via zonal centrifuge for high antigen purity, it contains influenza virus type A and type B hemagglutinin antigens (typically 45 μg per 0.5 mL dose). It is indicated for the prevention of influenza in children and adults, demonstrating robust immunogenicity with seroconversion rates exceeding 40% and seroprotection rates over 70% against all strains in phase III trials, meeting FDA criteria, and comparable safety to reference vaccines with no serious adverse events reported.[1][3][4][6][8][9]

Brand names

Ilyang Flu VaccineIL-YANG Flu VaccineIL-YANG FLU Vaccine INJ.IL-YANG FLU Vaccine Prefilled Syringe INJ

Other names

Kovax Influ PF Inj.